The FDA has approved three GLP-1s in particular for both type 2 diabetes treatment and weight loss: Liraglutide (Saxenda, Victoza): While effective, this once-daily injection generally leads to more modest weight loss compared to newer options (its been around since 2014)
Acute pancreatitis, gallbladder events, thyroid C-cell concerns (a rat-derived signal that has never been confirmed in humans), and diabetic retinopathy progression in patients with existing retinopathy
Others notice that they feel full sooner, eat less without forcing it, or stop thinking about food as often
PlexusDx provides compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan and supports your therapy with the Precision Peptide Genetic Test ($99 add-on) to identify your genetic response profile
,
Related research peptides available at FillerSupplies.com: Tirzepatide, Retatrutide, Tesofensine